A malaria vaccine is among 12 new technologies that will receive financial support from the LSU Board of Supervisors through its Leverage Innovation for Technology Transfer, or LIFT2, grant program during its ninth round of funding. Paul Rider, an assistant professor with the LSU Department of Pathobiological Sciences Research, is working on quantifying the specific
Malaria vaccine one of 12 new LSU LIFT2 grant recipients
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
